ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (42)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Polosa, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polosa, R.
Eur Respir J 2002; 20:488-496
Copyright ©ERS Journals Ltd 2002


Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease

R. Polosa

Dept of Internal and Specialist Medicine, University of Catania, Ascoli-Tomaselli Hospitals, Catania, Italy

CORRESPONDENCE: R. Polosa, Dipartimento di Medicina Interna e Specialistica, Università di Catania Ospedale Tomaselli, Via Passo Gravina 187, 95125, Catania, Italy. Fax: 39 095330707. E-mail: rp5@soton.ac.uk

Keywords: adenosine receptors, asthma, bronchoconstriction, chronic obstructive pulmonary disease, mast cell

Received: February 12, 2002
Accepted March 26, 2002

Abstract

Adenosine administration by inhalation elicits concentration-related bronchoconstriction in subjects with asthma and chronic obstructive pulmonary disease (COPD). The mechanisms of adenosine-induced bronchoconstriction appear to involve a selective interaction with activated mast cells with subsequent release of preformed and newly-formed mediators. Further evidence linking adenosine signalling to asthma and COPD comes from the finding that many cell types that play important roles in the exacerbation of these conditions express adenosine receptors and demonstrate relevant effects through stimulation of these receptors.

Therefore, blockade of these receptors may be a valuable approach to the treatment of asthma and chronic obstructive pulmonary disease. Promising adenosine-receptor targets for novel therapeutics of asthma and chronic obstructive pulmonary disease have recently been identified in a number of inflammatory cell types, including mast cells, eosinophils, lymphocytes, neutrophils, and macrophages. The recent characterisation of the A2B receptors indicates the human lung mast cell as one of the most strategic cellular targets.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. J. Mustafa, A. Nadeem, M. Fan, H. Zhong, L. Belardinelli, and D. Zeng
Effect of a Specific and Selective A2B Adenosine Receptor Antagonist on Adenosine Agonist AMP and Allergen-Induced Airway Responsiveness and Cellular Influx in a Mouse Model of Asthma
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1246 - 1251.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. Varani, G. Caramori, F. Vincenzi, I. Adcock, P. Casolari, E. Leung, S. MacLennan, S. Gessi, S. Morello, P. J. Barnes, et al.
Alteration of Adenosine Receptors in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., February 15, 2006; 173(4): 398 - 406.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. C. M. Obiefuna, V. K. Batra, A. Nadeem, P. Borron, C. N. Wilson, and S. J. Mustafa
A Novel A1 Adenosine Receptor Antagonist, L-97-1 [3-[2-(4-Aminophenyl)-ethyl]-8-benzyl-7-{2-ethyl-(2-hydroxy-ethyl)-amino]-ethyl}-1-propyl-3,7-dihydro-purine-2,6-dione], Reduces Allergic Responses to House Dust Mite in an Allergic Rabbit Model of Asthma
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 329 - 336.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. J. Oldenburg and S. J. Mustafa
Involvement of Mast Cells in Adenosine-Mediated Bronchoconstriction and Inflammation in an Allergic Mouse Model
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 319 - 324.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. C. Denlinger, G. Angelini, K. Schell, D. N. Green, A. G. Guadarrama, U. Prabhu, D. B. Coursin, P. J. Bertics, and K. Hogan
Detection of Human P2X7 Nucleotide Receptor Polymorphisms by a Novel Monocyte Pore Assay Predictive of Alterations in Lipopolysaccharide-Induced Cytokine Production
J. Immunol., April 1, 2005; 174(7): 4424 - 4431.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
B. Luijk, R.D. Kempsford, A.M. Wright, P. Zanen, and J-W.J. Lammers
Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction
Eur. Respir. J., April 1, 2004; 23(4): 559 - 564.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. Zhong, L. Belardinelli, T. Maa, I. Feoktistov, I. Biaggioni, and D. Zeng
A2B Adenosine Receptors Increase Cytokine Release by Bronchial Smooth Muscle Cells
Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 118 - 125.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. D. Khoa, M. C. Montesinos, A. J. Williams, M. Kelly, and B. N. Cronstein
Th1 Cytokines Regulate Adenosine Receptors and Their Downstream Signaling Elements in Human Microvascular Endothelial Cells
J. Immunol., October 15, 2003; 171(8): 3991 - 3998.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
L. Spicuzza, G.U. Di Maria, and R. Polosa
Adenosine levels in the exhaled breath condensate: a potential surrogate marker of airway inflammation
Eur. Respir. J., August 1, 2003; 22(2): 392 - 392.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the European Respiratory Society.